RMTI
Price:
$3.89
Market Cap:
$120.71M
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1998-01-27
Stock Exchange
NASDAQ
Ticker
RMTI
According to Rockwell Medical, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 123.22M. This represents a change of 110.87% compared to the average of 58.43M of the last 4 quarters.
The mean historical Enterprise Value of Rockwell Medical, Inc. over the last ten years is 183.26M. The current 123.22M Enterprise Value has changed 6.62% with respect to the historical average. Over the past ten years (40 quarters), RMTI's Enterprise Value was at its highest in in the June 2015 quarter at 769.98M. The Enterprise Value was at its lowest in in the June 2022 quarter at 4.47M.
Average
183.26M
Median
118.78M
Minimum
4.84M
Maximum
477.99M
Discovering the peaks and valleys of Rockwell Medical, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 903.54%
Maximum Annual Enterprise Value = 477.99M
Minimum Annual Increase = -91.05%
Minimum Annual Enterprise Value = 4.84M
Year | Enterprise Value | Change |
---|---|---|
2023 | 48.54M | 903.54% |
2022 | 4.84M | -91.05% |
2021 | 54.07M | 4.72% |
2020 | 51.63M | -63.35% |
2019 | 140.88M | 45.74% |
2018 | 96.67M | -66.36% |
2017 | 287.40M | -8.69% |
2016 | 314.75M | -34.15% |
2015 | 477.99M | 34.34% |
2014 | 355.82M | 1.19% |
The current Enterprise Value of Rockwell Medical, Inc. (RMTI) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
35.81M
5-year avg
59.99M
10-year avg
183.26M
Rockwell Medical, Inc.’s Enterprise Value is less than Lifecore Biomedical, Inc. (343.00M), less than Kamada Ltd. (296.47M), less than Intra-Cellular Therapies, Inc. (8.69B), greater than Agile Therapeutics, Inc. (7.87M), greater than Eagle Pharmaceuticals, Inc. (16.86M), greater than Regencell Bioscience Holdings Limited (102.76M), less than Procaps Group S.A. (473.19M), greater than Cumberland Pharmaceuticals Inc. (20.30M), greater than Incannex Healthcare Limited (40.05M), less than Aquestive Therapeutics, Inc. (427.93M), greater than Evoke Pharma, Inc. (508.40K), greater than Adamis Pharmaceuticals Corporation (-6593458674.00), greater than Guardion Health Sciences, Inc. (-10475955.00), greater than AcelRx Pharmaceuticals, Inc. (1.19M), greater than China SXT Pharmaceuticals, Inc. (-7758190.00), greater than Biofrontera Inc. (2.60M), greater than FSD Pharma Inc. (-639026.00), less than Acorda Therapeutics, Inc. (187.38M), greater than Lucy Scientific Discovery Inc. (2.06M), less than Collegium Pharmaceutical, Inc. (1.44B), less than Phibro Animal Health Corporation (1.36B), less than ANI Pharmaceuticals, Inc. (1.25B), greater than Silver Spike Investment Corp. (33.56M),
Company | Enterprise Value | Market cap |
---|---|---|
343.00M | $220.59M | |
296.47M | $344.30M | |
8.69B | $9.14B | |
7.87M | $10.43M | |
16.86M | $9.72M | |
102.76M | $105.66M | |
473.19M | $200.83M | |
20.30M | $16.07M | |
40.05M | $45.53M | |
427.93M | $468.96M | |
508.40K | $4.69M | |
-6593458674.00 | $7.25M | |
-10475955.00 | $4.35M | |
1.19M | $14.58M | |
-7758190.00 | $1.66M | |
2.60M | $5.54M | |
-639026.00 | $66.67K | |
187.38M | $821.03K | |
2.06M | $906.91K | |
1.44B | $1.05B | |
1.36B | $906.07M | |
1.25B | $1.18B | |
33.56M | $66.72M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rockwell Medical, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Rockwell Medical, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Rockwell Medical, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Rockwell Medical, Inc. (RMTI)?
What is the 3-year average Enterprise Value for Rockwell Medical, Inc. (RMTI)?
What is the 5-year average Enterprise Value for Rockwell Medical, Inc. (RMTI)?
How does the current Enterprise Value for Rockwell Medical, Inc. (RMTI) compare to its historical average?